Immediate Impact
39 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Bispecific antibodies: advancing precision oncology
2024 Standout
Works of Sam Grigg being referenced
Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high
2024
Systematic review with meta‐analysis: sirolimus‐ or everolimus‐based immunosuppression following liver transplantation for hepatocellular carcinoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sam Grigg | 63 | 114 | 19 | 92 | 11 | 359 | |
| Clark D. Kensinger | 17 | 101 | 7 | 77 | 20 | 316 | |
| S. Joseph Kim | 35 | 83 | 5 | 112 | 15 | 383 | |
| Michael Bolliger | 66 | 136 | 19 | 95 | 17 | 367 | |
| Costanza Canino | 38 | 101 | 5 | 98 | 6 | 312 | |
| T Malmstrom | 30 | 137 | 20 | 28 | 10 | 353 | |
| Brendan P. McMenomy | 63 | 160 | 40 | 53 | 18 | 315 | |
| Nikhil B. Amesur | 43 | 173 | 9 | 54 | 20 | 400 | |
| Joanna Duncan | 21 | 174 | 34 | 66 | 12 | 304 | |
| Little Jm | 44 | 190 | 22 | 22 | 24 | 326 | |
| Liana Langdon‐Embry | 249 | 120 | 1 | 223 | 12 | 391 |
All Works
Login with ORCID to disown or claim papers
Loading papers...